FDA Approves Pfizer Booster Shots for Seniors, High-Risk Americans
THURSDAY, Sept. 23, 2021 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday approved Pfizer booster shots for people over 65 and for those at high risk of severe COVID-19. Under the emergency use authorization, the booster shots should be given at least six months after a personContinue Reading